Viatris (VTRS)
(Real Time Quote from BATS)
$11.70 USD
+0.36 (3.18%)
Updated Sep 12, 2024 01:56 PM ET
3-Hold of 5 3
A Value F Growth D Momentum C VGM
Price, Consensus and EPS Surprise
VTRS 11.70 +0.36(3.18%)
Will VTRS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VTRS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VTRS
Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
VTRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Q2 Earnings Outpace Estimates, Sales Miss
Viatris (VTRS) Q2 Earnings Surpass Estimates
DocGo Inc. (DCGO) Q2 Earnings and Revenues Miss Estimates
Other News for VTRS
Viatris Inc (VTRS) Shares Up 3.35% on Sep 12
Viatris (VTRS) Shares Cross Above 200 DMA
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma